Recent publications have shown that obesity promotes liver dpp4 production, and liver-specific dpp4 transgenic mice displayed an elevated systemic dpp4 activity and diminished GLP-1 levels [9–12, 21]. The gene discussed is GCG; the disease is obesity disorder.